JK-206 showed good efficacy in the in vitro viability assay (Figure 2a,b), and through network analysis, we showed an association between RHOA and BIRC5 in the transcriptome dataset of JK-206-treated GC cell lines. Here, BIRC5 is linked to gastric cancer.